International Clinical Trial: Perioperative Tranexamic Acid (TXA) Administration in Metabolic Bariatric Surgery to Reduce Perioperative bleeding: A Double-blinded, 3-arm Randomized Controlled Trial

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (TCTR20250803003) titled 'Perioperative Tranexamic Acid (TXA) Administration in Metabolic Bariatric Surgery to Reduce Perioperative bleeding: A Double-blinded, 3-arm Randomized Controlled Trial' on Aug. 3.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: University Kebangsaan Malaysia (UKM)

Condition: To evaluate the effect of Tranexamic Acid (TXA) administration in perioperative bleeding, postoperative respiratory-related pain, and prolonged hospital stay in patients undergoing laparoscopic sleeve gastrectomy (LSG) Laparoscopic sleeve gastrectomy, bariatric surgery, obesity, bleeding, tranexamic acid, bariatric...